D-0299-2026 Class II Ongoing
FDA drug recall D-0299-2026 was initiated by Greenstone Llc on Jan 15, 2026 and is designated Class II. Reason for recall: Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil. The recall status is ongoing. Affected quantity: 3456 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 4, 2026
- Initiation Date
- Jan 15, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3456 cartons
Product description
methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21 Tablets, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977. NDC 59762-4440-2
Reason for recall
Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.
Distribution pattern
Nationwide within the United States
Code information
Lot # LG7675, Exp. Date Nov 2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0299-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026